I, A., R, G., B, C., N, R., & C, P. (2016). Letter: Faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors' reply. Alimentary pharmacology & therapeutics, 43(11), 1241. https://doi.org/10.1111/apt.13617
Chicago Style (17th ed.) CitationI, Ahmed, Greenwood R, Costello B, Ratcliffe N, and Probert C. "Letter: Faecal Volatile Organic Metabolites, Promising Biomarkers in Inflammatory Bowel Disease and Letter: Faecal Volatile Organic Metabolites as Novel Diagnostic Biomarkers in Inflammatory Bowel Disease. Authors' Reply." Alimentary Pharmacology & Therapeutics 43, no. 11 (2016): 1241. https://doi.org/10.1111/apt.13617.
MLA (9th ed.) CitationI, Ahmed, et al. "Letter: Faecal Volatile Organic Metabolites, Promising Biomarkers in Inflammatory Bowel Disease and Letter: Faecal Volatile Organic Metabolites as Novel Diagnostic Biomarkers in Inflammatory Bowel Disease. Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 43, no. 11, 2016, p. 1241, https://doi.org/10.1111/apt.13617.